Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
Journal
Journal for ImmunoTherapy of Cancer
ISSN
2051-1426
Date Issued
2019
Author(s)
Mehmet Altan
Vamsidhar Velcheti
Scott N. Gettinger
Roy S. Herbst
David L. Rimm
Kurt A. Schalper
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Subjects
pembrolizumab
;
association
;
sensitivity
;
nivolumab
;
blockade
;
tumors
;
aged
;
aged, 80 and over
;
b7 antigens
;
b7-h1 antigen
;
biomarkers, tumor
;
female
;
fluorescent antibody technique
;
humans
;
kaplan-meier estimate
;
lung neoplasms
;
lymphocytes, tumor-infiltrating
;
male
;
middle aged
;
neoplasm grading
;
neoplasm staging
;
prognosis
;
retrospective studies
;
small cell lung carcinoma
;
v-set domain-containing t-cell activation inhibitor 1
;
b7 h3 lymphocyte antigen
;
cd20 antigen
;
cd3 antigen
;
cd8 antigen
;
cytokeratin
;
lymphocyte antigen
;
programmed death 1 ligand 1
;
unclassified drug
;
v set domain containing t cell activation inhibitor 1
;
b7 antigen
;
cd274 protein, human
;
cd276 protein, human
;
programmed death 1 ligand 1
;
tumor marker
;
v set domain containing t cell activation inhibitor 1
;
vtcn1 protein, human
;
adult
;
aged
;
article
;
cancer infiltration
;
clinical feature
;
female
;
human
;
human tissue
;
immunofluorescence test
;
immunostimulation
;
immunotherapy
;
lymphocytic infiltration
;
major clinical study
;
male
;
overall survival
;
priority journal
;
protein expression
;
protein targeting
;
quantitative immunofluorescence test
;
regulatory mechanism
;
retrospective study
;
small cell lung cancer
;
tissue microarray
;
tumor associated leukocyte
;
cancer grading
;
cancer staging
;
fluorescent antibody technique
;
genetics
;
immunology
;
kaplan meier method
;
lung tumor
;
metabolism
;
middle aged
;
mortality
;
pathology
;
prognosis
;
small cell lung cancer
;
tumor associated leukocyte
;
very elderly